riboflavin solution + placebo solution
Phase 3Terminated 0 watching 0 views this week📈 Rising
74
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Keratoconus
Conditions
Keratoconus
Trial Timeline
Nov 1, 2013 → Apr 1, 2017
NCT ID
NCT01972854About riboflavin solution + placebo solution
riboflavin solution + placebo solution is a phase 3 stage product being developed by Glaukos for Keratoconus. The current trial status is terminated. This product is registered under clinical trial identifier NCT01972854. Target conditions include Keratoconus.
Hype Score Breakdown
Clinical
27
Activity
18
Company
7
Novelty
9
Community
10
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01972854 | Phase 3 | Terminated |
| NCT01344187 | Phase 3 | Completed |
| NCT01643226 | Phase 3 | Completed |
Competing Products
7 competing products in Keratoconus
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| riboflavin solution + placebo solution | Glaukos | Phase 3 | 74 |
| riboflavin ophthalmic solution | Glaukos | Phase 3 | 74 |
| GLK-221 Ophthalmic Solution + Placebo Ophthalmic Solution | Glaukos | Phase 2 | 49 |
| Riboflavin 5'-Phosphate | Glaukos | Approved | 82 |
| riboflavin solution + placebo solution | Glaukos | Phase 3 | 74 |
| Test Article A + Test Article B + Placebo | Glaukos | Phase 3 | 74 |
| Dextenza + Prednisolone Acetate | Ocular Therapeutix | Approved | 80 |